Logo

Becton Dickinson AbSeq Immune Discovery Panel

Jan 14, 2021

Becton Dickinson has launched a single-tube antibody-oligo-based discovery tool called the BD AbSeq Immune Discovery Panel (IDP). The panel contains 30 different pre-titrated antibodies targeting most major immune markers, is supplied in a dried format, and allows researchers to include additional immune markers of interest. It is designed for the BD Rhapsody Single-Cell Analysis System, and intended to be used alongside protein, RNA, and multiplexing assays to enable sequencing-based immune cell phenotyping.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.